Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-15-007903
Filing Date
2015-09-24
Accepted
2015-09-24 16:45:01
Documents
3
Effectiveness Date
2015-09-24

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS t1502205x2_defa14a.htm DEFA14A 23879
2 GRAPHIC logo.jpg GRAPHIC 37390
3 GRAPHIC sg_thomas-dagger.jpg GRAPHIC 19312
  Complete submission text file 0001571049-15-007903.txt   103450
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36410 | Film No.: 151123439
SIC: 2834 Pharmaceutical Preparations